-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $260

Benzinga·10/29/2025 18:04:21
Listen to the news
UBS analyst A.J. Rice maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $238 to $260.